Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 35

1.

Potential risk factors for celiac disease in childhood: a case-control epidemiological survey.

Bittker SS, Bell KR.

Clin Exp Gastroenterol. 2019 Jul 4;12:303-319. doi: 10.2147/CEG.S210060. eCollection 2019.

2.

Acetaminophen, antibiotics, ear infection, breastfeeding, vitamin D drops, and autism: an epidemiological study.

Bittker SS, Bell KR.

Neuropsychiatr Dis Treat. 2018 May 31;14:1399-1414. doi: 10.2147/NDT.S158811. eCollection 2018.

3.

Long-term Assessment of Post-Treatment Symptoms in Patients With Culture-Confirmed Early Lyme Disease.

Weitzner E, McKenna D, Nowakowski J, Scavarda C, Dornbush R, Bittker S, Cooper D, Nadelman RB, Visintainer P, Schwartz I, Wormser GP.

Clin Infect Dis. 2015 Dec 15;61(12):1800-6. doi: 10.1093/cid/civ735. Epub 2015 Sep 18.

4.

Utility of serodiagnostics designed for use in the United States for detection of Lyme borreliosis acquired in Europe and vice versa.

Wormser GP, Tang AT, Schimmoeller NR, Bittker S, Cooper D, Visintainer P, Aguero-Rosenfeld ME, Ogrinc K, Strle F, Stanek G.

Med Microbiol Immunol. 2014 Feb;203(1):65-71. doi: 10.1007/s00430-013-0315-0. Epub 2013 Nov 12.

PMID:
24218117
5.

Differences and similarities between culture-confirmed human granulocytic anaplasmosis and early lyme disease.

Wormser GP, Aguero-Rosenfeld ME, Cox ME, Nowakowski J, Nadelman RB, Holmgren D, McKenna D, Bittker S, Zentmaier L, Cooper D, Liveris D, Schwartz I, Horowitz HW.

J Clin Microbiol. 2013 Mar;51(3):954-8. doi: 10.1128/JCM.02929-12. Epub 2013 Jan 9.

6.

Differentiation of reinfection from relapse in recurrent Lyme disease.

Nadelman RB, Hanincov√° K, Mukherjee P, Liveris D, Nowakowski J, McKenna D, Brisson D, Cooper D, Bittker S, Madison G, Holmgren D, Schwartz I, Wormser GP.

N Engl J Med. 2012 Nov 15;367(20):1883-90. doi: 10.1056/NEJMoa1114362.

7.

Comparison of five diagnostic modalities for direct detection of Borrelia burgdorferi in patients with early Lyme disease.

Liveris D, Schwartz I, McKenna D, Nowakowski J, Nadelman R, Demarco J, Iyer R, Bittker S, Cooper D, Holmgren D, Wormser GP.

Diagn Microbiol Infect Dis. 2012 Jul;73(3):243-5. doi: 10.1016/j.diagmicrobio.2012.03.026. Epub 2012 May 8.

8.

Failure of topical antibiotics to prevent disseminated Borrelia burgdorferi infection following a tick bite in C3H/HeJ mice.

Wormser GP, Daniels TJ, Bittker S, Cooper D, Wang G, Pavia CS.

J Infect Dis. 2012 Mar 15;205(6):991-4. doi: 10.1093/infdis/jir382. Epub 2011 Sep 19.

9.

Improving the yield of blood cultures from patients with early Lyme disease.

Liveris D, Schwartz I, Bittker S, Cooper D, Iyer R, Cox ME, Wormser GP.

J Clin Microbiol. 2011 Jun;49(6):2166-8. doi: 10.1128/JCM.00350-11. Epub 2011 Apr 13.

10.

Blood cultures for patients with extracutaneous manifestations of Lyme disease in the United States.

Nowakowski J, McKenna D, Nadelman RB, Bittker S, Cooper D, Pavia C, Holmgren D, Visintainer P, Wormser GP.

Clin Infect Dis. 2009 Dec 1;49(11):1733-5. doi: 10.1086/648076.

PMID:
19886794
11.

A decline in C6 antibody titer occurs in successfully treated patients with culture-confirmed early localized or early disseminated Lyme Borreliosis.

Philipp MT, Wormser GP, Marques AR, Bittker S, Martin DS, Nowakowski J, Dally LG.

Clin Diagn Lab Immunol. 2005 Sep;12(9):1069-74.

12.

Microbiologic evaluation of patients from Missouri with erythema migrans.

Wormser GP, Masters E, Liveris D, Nowakowski J, Nadelman RB, Holmgren D, Bittker S, Cooper D, Wang G, Schwartz I.

Clin Infect Dis. 2005 Feb 1;40(3):423-8. Epub 2005 Jan 10.

13.

Variations in Barbour-Stoenner-Kelly culture medium modulate infectivity and pathogenicity of Borrelia burgdorferi clinical isolates.

Wang G, Iyer R, Bittker S, Cooper D, Small J, Wormser GP, Schwartz I.

Infect Immun. 2004 Nov;72(11):6702-6.

14.

Yield of large-volume blood cultures in patients with early Lyme disease.

Wormser GP, Bittker S, Cooper D, Nowakowski J, Nadelman RB, Pavia C.

J Infect Dis. 2001 Oct 15;184(8):1070-2. Epub 2001 Aug 29.

PMID:
11574924
15.

Characterization of Borrelia burgdorferi isolated from erythema migrans lesions: interrelationship of three molecular typing methods.

Iyer R, Liveris D, Adams A, Nowakowski J, McKenna D, Bittker S, Cooper D, Wormser GP, Schwartz I.

J Clin Microbiol. 2001 Aug;39(8):2954-7.

16.

Failure of treatment with cephalexin for Lyme disease.

Nowakowski J, McKenna D, Nadelman RB, Cooper D, Bittker S, Holmgren D, Pavia C, Johnson RC, Wormser GP.

Arch Fam Med. 2000 Jun;9(6):563-7.

PMID:
10862221
17.

Comparison of the yields of blood cultures using serum or plasma from patients with early Lyme disease.

Wormser GP, Bittker S, Cooper D, Nowakowski J, Nadelman RB, Pavia C.

J Clin Microbiol. 2000 Apr;38(4):1648-50.

18.

An indirect hemagglutination antibody test to detect antibodies to Borrelia burgdorferi in patients with Lyme disease.

Pavia CS, Wormser GP, Bittker S, Cooper D.

J Microbiol Methods. 2000 Apr;40(2):163-73.

PMID:
10699672
19.

Lyme disease: disparity between culture and polymerase chain reaction detection of Borrelia burgdorferi after exposure to ceftriaxone in vitro.

Varde S, Wormser GP, Nowakowski J, Nadelman RB, Bittker S, Cooper D, Schwartz I.

Conn Med. 1999 Oct;63(10):589-91.

PMID:
10578549
20.

Genetic diversity of Borrelia burgdorferi in lyme disease patients as determined by culture versus direct PCR with clinical specimens.

Liveris D, Varde S, Iyer R, Koenig S, Bittker S, Cooper D, McKenna D, Nowakowski J, Nadelman RB, Wormser GP, Schwartz I.

J Clin Microbiol. 1999 Mar;37(3):565-9.

21.

Improving the yield of blood cultures for patients with early Lyme disease.

Wormser GP, Nowakowski J, Nadelman RB, Bittker S, Cooper D, Pavia C.

J Clin Microbiol. 1998 Jan;36(1):296-8.

22.

Molecular typing of Borrelia burgdorferi from Lyme disease patients by PCR-restriction fragment length polymorphism analysis.

Liveris D, Wormser GP, Nowakowski J, Nadelman R, Bittker S, Cooper D, Varde S, Moy FH, Forseter G, Pavia CS, Schwartz I.

J Clin Microbiol. 1996 May;34(5):1306-9.

23.

The clinical spectrum of early Lyme borreliosis in patients with culture-confirmed erythema migrans.

Nadelman RB, Nowakowski J, Forseter G, Goldberg NS, Bittker S, Cooper D, Aguero-Rosenfeld M, Wormser GP.

Am J Med. 1996 May;100(5):502-8.

PMID:
8644761
24.

Evolution of the serologic response to Borrelia burgdorferi in treated patients with culture-confirmed erythema migrans.

Aguero-Rosenfeld ME, Nowakowski J, Bittker S, Cooper D, Nadelman RB, Wormser GP.

J Clin Microbiol. 1996 Jan;34(1):1-9.

25.

Sustained cellular immune responses to Borrelia burgdorferi: lack of correlation with clinical presentation and serology.

Horowitz HW, Pavia CS, Bittker S, Forseter G, Cooper D, Nadelman RB, Byrne D, Johnson RC, Wormser GP.

Clin Diagn Lab Immunol. 1994 Jul;1(4):373-8.

26.

Polymerase chain reaction amplification of culture supernatants for rapid detection of Borrelia burgdorferi.

Schwartz I, Bittker S, Bowen SL, Cooper D, Pavia C, Wormser GP.

Eur J Clin Microbiol Infect Dis. 1993 Nov;12(11):879-82.

PMID:
8112365
27.

Failure to isolate Borrelia burgdorferi after antimicrobial therapy in culture-documented Lyme borreliosis associated with erythema migrans: report of a prospective study.

Nadelman RB, Nowakowski J, Forseter G, Bittker S, Cooper D, Goldberg N, McKenna D, Wormser GP.

Am J Med. 1993 Jun;94(6):583-8.

PMID:
8506882
28.

Diagnosis of early Lyme disease by polymerase chain reaction amplification and culture of skin biopsies from erythema migrans lesions.

Schwartz I, Wormser GP, Schwartz JJ, Cooper D, Weissensee P, Gazumyan A, Zimmermann E, Goldberg NS, Bittker S, Campbell GL, Pavia CS.

J Clin Microbiol. 1992 Dec;30(12):3082-8.

29.

Vesicular erythema migrans.

Goldberg NS, Forseter G, Nadelman RB, Schwartz I, Jorde U, McKenna D, Holmgren D, Bittker S, Montecalvo M, Wormser GP.

Arch Dermatol. 1992 Nov;128(11):1495-8.

PMID:
1444504
30.

Passive immunization protects guinea pigs from lethal Toxoplasma infection.

Pavia CS, Bittker SJ, Curnick KE.

FEMS Microbiol Immunol. 1992 Jan;4(2):97-104.

PMID:
1547027
31.

Absence of infectious human immunodeficiency virus type 1 in "natural" eccrine sweat.

Wormser GP, Bittker S, Forseter G, Hewlett IK, Argani I, Joshi B, Epstein JS, Bucher D.

J Infect Dis. 1992 Jan;165(1):155-8.

PMID:
1345794
32.

Immune response to the Lyme spirochete Borrelia burgdorferi affected by ethanol consumption.

Pavia CS, Bittker S, Cooper D.

Immunopharmacology. 1991 Nov-Dec;22(3):165-73.

PMID:
1774157
33.

Antiborrelial activity of serum from rats injected with the Lyme disease spirochete.

Pavia CS, Kissel V, Bittker S, Cabello F, Levine S.

J Infect Dis. 1991 Mar;163(3):656-9.

PMID:
1995740
34.

Polymerase chain reaction for seronegative health care workers with parenteral exposure to HIV-infected patients.

Wormser GP, Joline C, Bittker S, Forseter G, Kwok S, Sninsky JJ.

N Engl J Med. 1989 Dec 14;321(24):1681-2. No abstract available.

PMID:
2586572
35.

The febrile father with a cytomegalovirus infection. A family affair.

Yarrish RL, Wormser GP, Bittker SJ, Aron-Hott L, Cabello F, Huang ES.

Postgrad Med. 1989 Jan;85(1):251-4.

PMID:
2536155

Supplemental Content

Loading ...
Support Center